Bahram Dideban

University of Florida

Papers

1

Total Citations

13

H-Index

1

About

Bahram Dideban is a researcher whose work centers on gynecologic oncology, with a particular focus on optimizing surgical outcomes for high-risk patient populations. His most cited study, "Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?" (2020), has garnered 13 citations and addresses a critical clinical question in postoperative care. This research highlights his contribution to evidence-based guidelines for thromboprophylaxis, specifically in obese patients undergoing robotic surgery—a group with elevated thromboembolic risk. By examining the balance between complication rates and prophylactic protocols, Dideban’s work informs safer surgical practices and personalized recovery strategies. His findings are particularly relevant given the rising prevalence of obesity and the increasing use of minimally invasive techniques in endometrial cancer treatment. Through this focused investigation, Dideban has advanced the conversation on perioperative management, offering actionable insights for clinicians. His research underscores a commitment to improving patient outcomes in gynecologic oncology, making him a valuable voice in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
13 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Florida

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago